Galencia

Zurich Switzerland
Biotech

Prolific dealmakers Akebia and Vifor pen anemia drug pact

Vifor Pharma has struck a deal to sell Akebia Therapeutics’ phase 3 oral anemia drug vadadustat through its network of U.S. dialysis centers.
Nick Paul Taylor May 16, 2017 5:42am
Zurich Switzerland

Vifor flies solo, plans spending spree as sister unit files IPO

Apr 7, 2017 2:38am
Newspapers

EuroBiotech:​​​ ​​​More​​​ ​​​Articles​​​ ​​​of​​​ ​​​Note

Mar 16, 2017 9:14am